Forbes November 7, 2024
The U.K. government plans to launch a real-time surveillence system to track respiratory disease and spot a future pandemic.
The “world-first” program will use rapid diagnostic technology from a private genomics company to identify and monitor potential outbreaks of bacterial or viral diseases, as well as antimicrobial resistance.
Oxford Nanopore’s molecular sensing technology can analyse genes and pathogens quickly, speeding up the diagnosis of things like infectious disease and cancer.
The U.K. wants to use the tech on patients with suspected severe acute respiratory infections. It should allow doctors to accurately diagnose their disease — and choose the best available treatment — within six hours.
This is much faster than the polymerase chain reaction (PCR) tests many members of the...
Today's Sponsors
Today's Sponsor